All 1 tracked stories fall under one category: pharma. Doceree is most often covered alongside AI, which appears in 1 of these 1 story. Source depth averages 2 original sources per story, versus 2.4 across the same-window beat baseline. Their average consequence score of 6 sits level with the 6 recorded across the beat in that window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Doceree
All 1 tracked stories fall under one category: pharma. Doceree is most often covered alongside AI, which appears in 1 of these 1 story. Source depth averages 2 original sources per story, versus 2.4 across the same-window beat baseline. Their average consequence score of 6 sits level with the 6 recorded across the beat in that window. We currently track 1 Biotech story that mention Doceree, all published on February 19, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 27 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Doceree. Shared-story counts are live from our verified record — not editorial picks.
Doceree has unveiled Admanager, an AI-driven platform specifically engineered to empower healthcare publishers in managing their digital advertising ecosystems. The tool aims to streamline HCP targeting and data sovereignty, addressing long-standing inefficiencies in the pharmaceutical marketing supply chain.